Selpercatinib by Loxo Oncology for Salivary Gland Cancer: Likelihood of Approval

Selpercatinibis under clinical development by Loxo Oncology and currently in Phase II for Salivary Gland Cancer.

Related Keywords

Selpercatinib Retevmo , ,